Case Report

Page 2

PCC
Recurrence of Tolosa-Hunt Syndrome
Case Report

September 3, 2024

The authors present a unique presentation of ipsilateral recurrence of Tolosa Hunt syndrome involving the sixth cranial nerve in a 64-year-old man.
, , , et al
PCC
Adalimumab-Associated Depressive Symptoms in VAIHS
Case Report

August 29, 2024

A 16-year-old boy with vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome, who was taking adalimumab, presented with features of depression.
, ,
PCC
Unremitting Nausea Due to Lurasidone After Semaglutide Initiation
Case Report

August 29, 2024

The potential drug interaction between lurasidone and semaglutide causing new intolerable nausea following lurasidone administration is described in the case of a 35-year-old woman.
, ,
JCP
SSRI Discontinuation and AUD Relapse
Case Report

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to...
, , , et al
PCC
Panic Attacks Masquerading as Intractable Vomiting
Case Report

August 22, 2024

While symptoms such as a racing heart, sweating, trembling, shortness of breath, chest pain, dizziness, and a sense of losing control or dying are obvious hallmarks of a panic...
, ,
PCC
Delusional Disorder and PMDD With Antipsychotic-Induced Hyperprolactinemia
Case Report

August 15, 2024

A patient diagnosed with PMDD developed delusional disorder, with marked variability in symptom severity correlating with the menstrual cycle, as well as hyperprolactinemia after starting antipsychotic treatment.
,
PCC
Sexsomnia and Dhat Syndrome in an Adolescent Male
Case Report

August 8, 2024

A 17-year-old boy presented with sexsomnia and Dhat syndrome, a culture-bound syndrome characterized by excessive concerns about semen loss and its perceived health consequences.
,
PCC
Steroid-Induced Musical Hallucinosis
Case Report

August 8, 2024

A 59-year-old man with no prior psychiatric history developed musical hallucinations following the administration of methylprednisolone.
, ,
PCC
Allopurinol for Resistant Mania
Case Report

August 1, 2024

This case report contributes to evidence supporting the therapeutic effectiveness of allopurinol in managing a complex clinical presentation involving comorbid mania, hyperuricemia, and gout.
, ,
PCC
Catatonia in a Patient With Hypothyroidism Due to Levothyroxine Nonadherence
Case Report

August 1, 2024

This report describes a case of catatonia in the context of a 72-year-old patient with nonadherence to thyroxine who developed severe hypothyroidism.
, , , et al
PCC
ECT for Catatonia With NPSLE, Epilepsy, and Cerebral Palsy
Case Report

July 25, 2024

An 18-year-old patient with neuropsychiatric systemic lupus erythematosus, epilepsy, and cerebral palsy who developed benzodiazepine-refractory catatonia and immunosuppression experienced complete resolution of symptoms after 20 ECT treatments.
, , , et al
PCC
Hallucinations Following IV Tapentadol Use
Case Report

July 23, 2024

The authors describe 2 cases of individuals who developed tapentadol-induced hallucinations in clear consciousness following nonprescribed intravenous use.
, , , et al
PCC
Clozapine-Related Cecal Volvulus
Case Report

July 11, 2024

This case of clozapine-related cecal volvulus illustrates the need for a high index of suspicion for potentially life-threatening surgical emergencies in clozapine-treated patients.
, , , et al
PCC
Role of Psychiatry and Clinical Ethics in Life-Sustaining Treatment Withdrawal
Case Report

July 9, 2024

The authors discuss the roles of psychiatry and clinical ethics consultants and compare demoralization with major depressive disorder through analysis of the ethical dimensions of withdrawing life-sustaining hemodialysis in...
,
PCC
Phentermine-Related Tardive Dyskinesia
Case Report

June 27, 2024

This report describes a patient prescribed phentermine for low energy and weight control, who subsequently developed tardive dyskinesia a month after starting the medication.
, , , et al
PCC
Prazosin 3 Times Daily for PTSD-Induced Psychological Distress
Case Report

June 25, 2024

This report discusses utilization of a 3-times-daily prazosin dosing scheme during a hospital admission for a patient experiencing severe nightmares and daytime flashbacks associated with PTSD.
, , , et al
PCC
CTE Presenting as Psychogenic Nonepileptic Seizures
Case Report

June 11, 2024

This case of a 14-year-old boy with a history of TBIs highlights the evolution of neuropsychiatric effects, leading to multiple differential diagnoses attempting to explain his symptoms.
, ,
PCC
Psychosis With Use of an Herbal Chinese Slimming Product
Case Report

June 11, 2024

A woman with no underlying mood disorder experienced psychotic symptoms after taking an herbal appetite suppressant.
, , , et al
PCC
ECT for Depression in a Patient With Takotsubo Cardiomyopathy History
Case Report

June 4, 2024

A patient with a recent history of Takotsubo cardiomyopathy was safely and effectively treated for depression with ECT.
, ,
PCC
Montelukast-Associated Psychosis in Children
Case Report

May 28, 2024

Two children experienced auditory visual hallucinations after taking montelukast for 1 to 2 days for asthma.
, , , et al
PCC
Psychiatric Symptoms of Creutzfeldt-Jakob Disease
Case Report

May 21, 2024

This case highlights the difficulty in controlling symptoms such as agitation and visual hallucinations in patients with Creutzfeldt-Jakob disease.
, , , et al
PCC
Parry-Romberg Syndrome Presenting as OCD
Case Report

May 7, 2024

This case of late-onset Parry-Romberg syndrome (PRS) presenting with OCD and abnormal cavum septum pellucidum highlights the role of embryonic neurodevelopment in the etiopathogenesis of PRS.
, , , et al
PCC
Inhalant Screening in Early Adolescence
Case Report

April 25, 2024

The authors present a case of polysubstance use in an adolescent for whom undetected inhalant use played a key role in escalation of substance use and psychiatric comorbidities.
, , , et al
PCC
Psychotic Symptoms Following Ayahuasca Use
Case Report

April 11, 2024

A 43-year-old woman with no psychiatric history developed schizophreniform psychotic symptoms after taking ayahuasca, which resolved after 1 week of risperidone treatment.
, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe